Retatrutide 40mg (R&D Only)

€200.00

Technical Specifications

Specification	Detail
Product Name	Retatrutide (LY3437943) – R&D Only
CAS Number	2381089-83-2
Molecular Formula	C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight	4731.33 Da
Purity	≥98% (HPLC verified)
Appearance	White to off-white lyophilized solid
Solubility	H₂O: 20 mg/mL; DMSO: 50 mg/mL
Target Receptors	GLP-1R, GIPR, GCGR
Mechanism	Triple hormone receptor agonist
Storage (Powder)	-20°C to -80°C; protect from light/moisture
Storage (Reconstituted)	2-8°C; aliquot for freezing
Stability (Powder)	2 years at -80°C; 1 year at -20°C
Stability (Solution)	6 months at -80°C; 1 month at -20°C
Shipping	Ambient with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis, Safety Data Sheet

Category: Buy Peptide Online EU Tags: -20c peptide storage, -80c peptide storage, 0.22 micron filter, 1099, 10mg vial, 2-AG, 20mg vial, 21 CFR Part 11, 24/7 monitoring, 2FA, 3PL, 401k, 40mg vial, 4PL, 5-HT3, 503A pharmacy, 503B outsourcing facility, 505(b)(1), 505(b)(2), 505(j), 5mg vial, AASLD, ABAC, abbreviated new drug application, ABSL, absorption, abstract submission, ABY, ABY3, academic lab supplies, academic-industry partnership, ACC, ACC annual session, accelerated stability, accelerometer, acceptable daily intake, access control, account takeover, accuracy, Acetate salt, acetylation, acetylcholine, achat retatrutide France, acid-base balance, acid-sensing ion channel, acknowledgements, ACTH, action potential, active container, Active Directory, Acushnet, Adams County, adaptive authentication, Addison County, additive secret sharing, adductomics, adenosine, adenylation domain, adequacy decision, adequacy determination, ADI, ADI-M, adipocyte research, adipokine analysis, adiponectin, ADME, ADN, ADR, adverse event, adverse outcome, adverse outcome pathway, adware, AE, AF4, affirmative action, aggregation, agouti-related peptide, agricultural research, AgRP, AHA, AHA scientific sessions, aid, air cargo, air freight, air pollution, air quality management district, air sampling, air toxics, airway bill, alarm system, Albany County, albumin, albumin binding, ALCOA, algorithmic stablecoin, Allegany County, Allegheny County, ALP, alpha-helix, alpha-MSH, ALS, ALT AST, alternative methods, Alzheimer disease, ambient shipping, amendment, American Diabetes Association, amino acid analysis, AML, AMPA, amperometry, amphipathic peptide, amyloid, amyloidosis, analytical method validation, analytical standard peptides, analytical ultracentrifugation, anandamide, and disposal facility, ANDA, Androscoggin County, animal biosafety level, Animal ethics, animal model research, animal opsins, animal science, animal study peptides, Anne Arundel County, Annex 11, Anonymization, ANOVA, anti-boycott, anti-corruption, anti-discrimination, anti-malware, anti-money laundering, antisense oligonucleotide, antivirus, ANVISA, AO, AOP, apamin, API security, appetite regulation research, application security, aptamer, AQMD, Aquinnah, AR, arbitration, archaerhodopsin, area source, Arg9, arginine-rich peptide, Aroostook County, arsenic, arsenic chelation, aseptic processing, ASIC, ASO, Astrocyte, asymmetric flow field-flow fractionation, atherosclerosis research, ATO, ATP, ATP bioluminescence, ATP-sensitive potassium channel, ATR, attainment area, attribute-based access control, AUC, augmented reality, Austrian lab supplies, authentication, authorization, authorship, Authy, autoclave, autoclave validation, autophagy, autophagy-lysosome pathway, avoid freeze thaw peptides, AWS, AWS Europe, axon, Azure, Azure AD, B Corp, background potassium channel, bacterial endotoxin, BAL, balance calibration, Baltimore, Baltimore County, Barnstable, baroreception, Barrington, base editing, base station, baseline requirements, batch number, batch release, Bay Area AQMD, BBSRC, BCR, Beacon, BEC, Bedford, behavioral biometrics, BeiDou, Belgian research chems, Belknap County, benchmark dose, beneficial use, benefit corporation, Bennington County, Bergen County, Berkley, Berks County, Berkshire County, best peptide site Europe, bestellen retatrutide, beta-endorphin, beta-MSH, beta-peptide, beta-sheet, beta-turn, Bethany, BFV, BGV, bill of lading, binding corporate rules, bioactive peptides, bioanalytical standards, bioavailability, bioburden, biochemistry, bioinformatics, biolayer interferometry, biologics license application, biomarker, biomarker of effect, biomarker of exposure, biomarker of susceptibility, biometric authentication, bioorthogonal chemistry, biopharma sourcing, bioresearch tools, bioRxiv, biosafety, Biosafety cabinet, biotech reagents, Bitcoin, BLA, black lipid membrane, BLI, blinding, BLM, Block Island, blockchain, blocking, blood pressure regulation, bloodborne pathogens, blue team, BMD, board certification, body composition analysis, body composition research, body weight tracking, bombolitin, botnet, Bourne, Bradford County, Branford, breach notification, breakbulk shipping, brevinin, Brewster, Brexit, bribery act, Bridgeport, Bristol, Bristol County, bromide, Bronxville, Broome County, brownfield, browser fingerprint, browser trust, brute force attack, BSL, BSL-1, BSL-2, BSL-3, buffer preparation, buforin, bulk shipping, Burlington County, business continuity, business email compromise, business interruption insurance, buy GLP-1 Europe, buy peptides EU compliant, Buy peptides online, buy research compounds, buy retatrutide, buy retatrutide 10mg, buy retatrutide eu, buy Semaglutide EU, buy tirzepatide Europe, C. elegans, C2, C5, CA, CA/Browser Forum, Cachexia research, Caco-2 cells, cadmium, cadmium chelation, CADTH, CADY, Cajal body, calcium channel, Calcium flux, calcium homeostasis, Calcium imaging, calcium release channel, Caledonia County, California ETS, CAM, Camden, Camden County, cancellation policy, cancer risk assessment, candidate selection, cannabinoid receptor, canvas fingerprint, cap and trade, CAR, Carbon County, carbon credit, carbon footprint, carbon monoxide, carbon negative, carbon neutrality, carbon offset, carbon tax, cardiology societies, Cardiovascular research, career development, carrier protein, Carroll County, Carver, Cas9, CASB, cat, cathelicidin, Cattaraugus County, Cav, Cayuga County, CB1, CB2, CBD, CCT, CD, CDA, CDM, CDx, CE marking, CEA, Cecil County, cecropin, cell, cell based assays, cell biology, cell culture peptides, Cell therapy, cell-penetrating peptide, CEMS, Central Falls, CEO fraud, CERCLA, CERCLA site, CERT, certificate authority, Certificate of Analysis, certificate of origin, certificate program, certification, certification audit, ceruloplasmin, CFTR, cGMP, CGRP, channelrhodopsin, chaperone, chaperonin, characteristic waste, characterization, chargeback fraud, charitable organization, Charlestown, chart recorders, Chatham, Chautauqua County, chelation therapy, chelator, chemical compatibility, chemical hygiene plan, chemical safety, chemical waste, cheminformatics, Chemogenetics, chemosensing, Chemung County, Chenango County, Cheshire County, Chester, chilled transport, Chilmark, China ETS, Chittenden County, chloride channel, chlorotoxin, cholesterol analysis, Chromatin remodeling, chromium, chromogenic LAL, circular dichroism, CIS benchmarks, Cisco, Citation analysis, CITES, civil liberties, CJD, CKKS, claims data, Clark County, Clarkstown, classification, ClC, clean development mechanism, clean room, cleanroom behavior, cleanup, clearance, click chemistry, client certificate, client-to-authenticator protocol, climate change, climate neutrality, climate positive, clinical chemistry, clinical endpoint, clinical pharmacist, Clinical research, clinical trials, clinicaltrials.gov, Clinton, Clinton County, CLIP, closure, cloud access security broker, CLOUD Act, cloud computing compliance, cloud region, cloud security, cloud security posture management, cloud workload protection platform, ClpB, cluster analysis, Cmax, CME, CMMC, CNG, CO, CO2, COA request, coactivator, cobalt, COBRA, code signing, code signing certificate, codeine, coiled coil, cold chain, cold chain logistics, cold chain shipping peptides, cold storage, collagen triple helix, collectible, Columbia County, combination packaging, combustion, command and control, commercial invoice, commodity code, community pharmacist, companion diagnostic, comparative medicine, compartmental modeling, compass, compatibility, compendial methods, compliance, compliance assurance monitoring, compliance audit, compliance certification, composite packaging, compounding pharmacy, comprar retatrutide España, comprehensive environmental response compensation and liability act, computational PIR, computer security incident response team, condensate, condensation domain, conductance, Conference of the Parties, conferences, confidentiality agreement, configuration management, confined space, conotoxin, conscious capitalism, consensus algorithm, consent, constrained peptide, construction permit, consumer rights, contact plates, container security, container shipping, contaminant, contingency planning, continuing education, continuous authentication, continuous emission monitoring system, contract, contract logistics, controlled substances, cookie policy, Cooling off period, Coos County, COP, COP26, COP27, COP28, copper chelation, copper homeostasis, Corda, corepressor, corporate social responsibility, corrective action, corrosion resistance, cortistatin, Cortland County, Cortlandt, Cost effectiveness analysis, cost-utility analysis, Cox regression, CPD, CPP, Cranston, crash, credential stuffing, credit card fraud, CRISPR, criteria air pollutant, CRO services peptides, cross-border data flow, cross-docking, crosslinking enzyme, cryo-EM, crypto winter, Cryptocurrency, crystallin, CSIRT, CSPM, CSR, CTAP, CUA, Cumberland County, current clamp, current good manufacturing practices, curve fitting, custom peptide synthesis, customer due diligence, customs broker, customs tariff, Cuttyhunk, CV, CWPP, cyber liability, Cybersecurity, cyclase, cyclic nucleotide-gated channel, cyclic voltammetry, cytokine analysis, Czech peptides, D-peptide, DAI, DALY, dangerous goods, Danish peptides, DAP, Darien, Dartmouth, DAST, data adequacy, data at rest, Data breach, data controller, data exfiltration, data governance, data in transit, data integrity, data leak, data localization, data logger, data loggers, data management, data privacy, data processor, Data protection, data residency, Data sharing, data subject, data transfer, Dauphin County, db/db mice, DDoS attack, DDP, de-identification, deacetylation, decontamination, deemed export, deemed re-export, Deep River, defensin, deferasirox, deferiprone, deferoxamine, degenerin, Delaware County, delegated proof of stake, delivery network, delivery terms, delta receptor, demethylation, dendrite, denied parties list, Dennis, depeg, dependency check, dephosphorylation, depyrogenation oven, dermal contact, dermaseptin, design of experiments, designer receptor exclusively activated by designer drug, detergent residue, deubiquitination, development assistance, development finance, developmental biology, device fingerprint, DevSecOps, DFARS, diabetes research peptide, diabetes UK, diabetic nephropathy, Diem, differential privacy, differential pulse voltammetry, differential scanning calorimetry, digestion simulation, Dighton, digital art, digital certificate, digital rights, digital signature, dimerization, DIO mice, disability insurance, disability-adjusted life year, disaster recovery, disaster relief, discharge, discreet shipping peptides, disease ecology, disease mapping, disease registry, disordered region, dispute resolution, Distance selling, distributed ledger, distribution, distribution network, District of Columbia, disulfide bond, DLS, DLT, DMPS, DMSA, DMSO peptide solubility, DnaJ, DnaK, DNS, DNSSEC, docker security, document signing, document signing certificate, DoE, dog, DOL, domain name, domain validation certificate, dopamine, Dose response, DPIA, DPoS, DPV, DREADD, drop test, Drosophila, DRPLA, Drug discovery, drug establishment registration, drug listing, drug rediscovery, drug repositioning, Drug repurposing, drug rescue, dry heat sterilization, dry ice shipping, DSC, DTPA, dual agonist, dual-use items, dual-use regulation, Dubai, Duo, Dutch research chemicals, Dutchess County, DV certificate, DXA scan, dynamic light scattering, dynorphin, e-beam irradiation, e-manifest, E&L, E&O, EAR, early career investigator, EASD, EASD annual meeting, EASL, EASO, East Greenwich, East Haven, East Lyme, East Providence, Eastchester, Eastham, EB, EC50, EC50 values, echoMRI, Edgartown, EDTA, EEOC, efficacy, EHR, eIDAS, EIS, elastin-like polypeptide, electrical safety, electrochemical impedance spectroscopy, electrolyte balance, electronic health record, electronic lab notebook, electronic records, electronic signature, electronic signatures, electrophysiology, Elizabeth Islands, ELN, ELPylation, EMA registration, email certificate, Emax, embargo, emergency action plan, emergency power, emergency response, emission, emissions trading scheme, EMP-toolkit, employee benefits, employee stock purchase plan, employment law, EMR, ENaC, encryption, end-user certificate, end-user statement, ENDO, ENDO meeting, ENDO-ERN, Endocannabinoid, endocrinology societies, endomorphin, endotoxin detection, endotoxin limit, endotoxin unit, endpoint protection, energy expenditure research, enhanced due diligence, enkephalin, enteroendocrine cells, environmental epidemiology, environmental exposure, environmental hazards, environmental health, environmental monitoring, environmental protection agency, environmental social governance, environmentally hazardous substance, enzymatic hydrolysis, enzyme-linked receptor, EP, EPA, epidemiology, Epigenetics, epimerization domain, epinephrine, epithelial sodium channel, equal opportunity, equity compensation, ERC, Erie County, ERISA, errors and omissions, ESC, ESC congress, esculentin, ESE, ESG, ESPP, Essex, Essex County, Ether, Ethereum, ethical approval, ethical hacking, ethics committee, ethylene oxide, ETS, EU Clinical Trials Register, EU data boundary, EU ETS, EU GDPR, EU regulation, EU sanctions, EU trade deals, EU warehouse peptides, EU-UK trade deal, EU-US Data Privacy Framework, EU/mg, EUC, eupeptideshop, eupeptideshop.org, EUR.1, European Association for the Study of Diabetes, European Commission, European Pharmacopoeia, EV certificate, exclusivity, excretion, executive order, Exeter, experimental design, expiry date, export administration regulations, export control, export license, exportin, exposome, exposomics, exposure assessment, exposure pathway, exposure route, exposure scenario, exposure-response, extended reality, extended validation certificate, external audit, extractables, EXW, face ID, factorial design, Fairfax County, Fairfield, Fairfield County, Fairhaven, Falmouth, FASEB, fatty acid conjugation, fatty liver research peptide, Fc fusion, FCA, FCPA, FDA registration, FDA-registered facility, federal implementation plan, federated learning, federation, FedRAMP, ferritin, FFF, FFI, FHE, fibril formation, fibrosis assessment, FICA, FIDO, FIDO2, field flow fractionation, final product testing, final report, financial crime, financial inclusion, fine, fingerprint, Finnish lab reagents, FIP, fire safety, firewall, first aid, FISA, Fishers Island, Fishkill, fleet management, FLIPR, flow cytometry, fluid balance, Fluo-4, fluoride, fluorinated gases, FMOC synthesis, foldamer, food intake measurement, food science, food-derived peptides, force feedback, forced degradation studies, foreign aid, foreign intelligence surveillance, foreign national, foundation, fourth-party logistics, Franklin County, fraud prevention, freedom to operate, Freetown, freezer validation, freezer warehouse, freight forwarder, freight forwarding, French peptide supplier, FRESCO, friendly fraud, frozen transport, FTD, fugitive emission, fully homomorphic encryption, Fulton County, Fume hood, functional assays, functional foods, funding sources, Fura-2, FUS proteinopathy, FUTA, FV, FXR, G protein-coupled receptor, G protein-gated inward rectifier potassium channel, GABA, GABA-A, GABA-C, GACT, gait analysis, Galileo, gamma irradiation, gamma-MSH, gamma-peptide, gamma-turn, gap analysis, garbled circuit, Gardiners Island, gasification, gastrointestinal stability, Gay Head, GCaMP, GDPR, Geary's C, GECI, gel clot, Gene editing, gene therapy, generally available control technology, generator, Genesee County, genetic polymorphism, genetic variation, genetically encoded calcium indicator, genetically encoded voltage indicator, genetics, genomics, geofencing, geographic information system, geolocation, geostatistics, geotagging, German peptide supplier, GEVI, Ghrelin, GHS, GHS pictograms, GIP GLP-1 agonist, GIRK, GIS, Glasgow, glasses, glassware cleaning, glassware washing, Global health, global positioning system, global supply chain, global warming, GLONASS, Gloucester County, gloved fingertip, GLP studies, GLP-1 agonists for research, GLP-1 GIP GCG agonist, GLP-1 peptide buy, glucagon receptor agonist, glucose homeostasis research, glucose uptake assay, glutamate, glycine, glycine receptor, glycoengineering, glycopeptide, glycoprotein, glycosylation, glycosyltransferase, GMP certification, GMP peptides, goggles, Google Authenticator, Google Cloud, Google Cloud Europe, Google Scholar, Gordon Research Conferences, Goshen, Gosnold, governing law, government access, gowning, GPCR, GPS, Grafton County, Grand Isle County, grant support, grantmaking, Greek lab supply, Greenburgh, Greene County, greenhouse gas, Greenwich, GroEL, GroES, Groton, groundwater monitoring, GrpE, GSS, Guilford, gut health, Gut microbiome, gut peptide research, gyroscope, h-index, half-life, half-life extension, halogenase, halorhodopsin, Hamden, Hamilton County, Hampden County, Hampshire County, Hancock County, HAP, haptic controller, haptic glove, haptic suit, haptics, hardening, Harford County, Harriman, Harrison, Hartford County, Harwich, HAS, HAT, Haverstraw, hazard class, hazard communication, hazard index, hazard labeling, hazard quotient, hazard statements, hazardous air pollutant, hazardous substance, hazardous waste, hazardous waste determination, hazardous waste landfill, hazardous waste manifest, HAZCOM, hazmat, HBD, HCN, HDAC, HEAAN, headset, Health Canada, health economics, health geography, health insurance, hearing conservation, heart failure research, heat shock protein, heavy lift, heavy metal poisoning, heavy metals, HElib, hemopressin, hepatocyte research, hERG, Herkimer County, heterocycle, heterodimer, HI, high purity peptides, high purity research chemicals, high purity synthesis, Hill coefficient, Hillsborough County, HIPAA, HIPAA privacy, HIPAA security, Histamine, histone derived peptide, Histone modification, HITECH, HMT, HNP, homodimer, homomorphic encryption, Horizon Europe, hospital pharmacist, hot work, HOTP, hotspot analysis, HotStuff, Howard County, HQ, HS code, HSA fusion, HSP, HSP40, HSP60, HSP70, HSP90, HtpG, HTTPS, HTTPS everywhere, hub and spoke, Hudson County, human rights, humanitarian aid, humanitarian logistics, Hungarian research chems, Hunterdon County, Huntington disease, hydrocarbon stapling, hydrogen sulfide, hydrostatic pressure test, hydroxylase, Hyperledger, hyperpolarization-activated cyclic nucleotide-gated channel, hypocretin, hypothesis testing, IaaS, IACUC, IAM, IANA, IAST, IATA, IATA DGR, IBC, IBFT, IC50, ICANN, ICAO TI, ICER, ICH guidelines, ICH Q2, identity and access management, identity federation, identity governance and administration, identity provider, identity theft, IDP, IGA, IMDG Code, immigration law, immunology, Impact factor, impact investing, implementing decision, import license, importin, impurity profiling, IMU, in situ intestinal perfusion, in vitro research peptides, in vivo absorption, in vivo research peptides, in-process control, incentive stock option, incident response, incineration, inclusive finance, Incoterms, incremental cost-effectiveness ratio, incretin research, incubator validation, IND enabling studies, indemnification, independent contractor, indirect calorimetry, industrial hygiene, inertial measurement unit, inflammation markers, INFOGEST, information-theoretic PIR, ingestion, inhalation, injection, inner packaging, inside-out tracking, institutional approval, institutional biosafety, institutional biosafety committee, insulated container, insulin secretion assay, intellectual property, interferometric scattering microscopy, intermediate packaging, intermediate precision, intermodal transport, internal audit, internal dose, internet governance, interoception, intestinal barrier, intrinsically disordered protein, invalidated, inventory management, investigational peptide, invoice, invoice fraud, inward rectifier potassium channel, iodine homeostasis, ion channel, ion flux, ion homeostasis, ionotropic glutamate receptor, IP geolocation, IP leak, IP protection, IP3 receptor, IQWIG, IR plan, Irish research reagents, IRNSS, iron chelation, iron homeostasis, iSCAT, ISG15, ISGylation, ISO, ISO 27001, ISO 9001, ISO class, isothermal titration calorimetry, Istanbul BFT, Italian peptides, ITAR, ITC, itch, Jamestown, Janoshik tested retatrutide, JEA, Jefferson County, JI, JIT, Johnston, joint implementation, JP, jurisdiction, just-enough access, just-in-time access, k-anonymity, K-ATP, K2P, kainate, Kaplan-Meier, kappa receptor, karyopherin, KBA, KCNQ, KDM, KE, Kennebec County, Kennedy disease, Kent County, key event, keylogger, Keystone Symposia, keystroke dynamics, keyword PIR, KFDA, kidney health, kinase, Kir, know your customer, knowledge-based authentication, Knox County, kopen retatrutide Nederland, Kriging, Kubernetes security, Kuru, Kv, KYC, l-diversity, lab reagent, lab safety, lab safety plan, lab tested peptides EU, label, labor law, laboratory information management system, laboratory peptides Netherlands, Lackawanna County, lactam bridge, lactoferrampin, lactoferricin, LADD, Lakeville, LAL test, Lamoille County, Lancaster County, land disposal restrictions, landfill, landscape epidemiology, Larchmont, last-mile delivery, Lattigo, law enforcement access, LBS, LC-MS standards, LDAP, LDR, leachables, leachate collection, leaching, lead, lead chelation, lead optimization, leak channel, leakproofness test, Lebanon County, legal agreement, legal basis, legitimate interest, Lehigh County, leptin, leveled fully homomorphic encryption, Lewis County, Lewisboro, LGIC, LHE, liability disclaimer, liability insurance, LibraBFT, licensing agreement, life insurance, lifetime average daily dose, ligand-gated ion channel, light sensing, lighthouse, limitation of liability, LIMS, Lincoln, Lincoln County, line extension, linear regression, linearity, liner, lipid droplet staining, lipid metabolism peptides, lipidation, Lipidomics, liquid-liquid phase separation, LISA, listed waste, Litchfield County, literature search, Little Compton, liver enzymes, liver fibrosis research, liver histology, liver meeting, liver society, Livestock, Livingston County, LL-37, LLPS, LOAEL, local air district, local indicators of spatial association, localization, location-based service, lockout tagout, LOD, logistic regression, logistics management, logistics partner, logistics service provider, loop, LOQ, lot number, LOTO, lowest observed adverse effect level, LSP, LTD, LTP, Luna, Luzerne County, LXR, LY3437943 buy, LY3437943 EU, Lyme, lyophilized peptide, lysosome, macrocycle, MACT, Madaket, Madison, Madison County, magainin, magnesium homeostasis, magnetometer, mail-order pharmacy, major source permit, MALS, malware attack, Mamaroneck, mandate fraud, manganese, MANOVA, manufacturing date, mapping, margin of exposure, margin of safety, Maricopa County, marine natural product, marine pollutant, Marion, Martha's Vineyard, MASCOT, Mashpee, MASLD research, mass photometry, mass spec analysis, mastoparan, material compatibility, material transfer, material transfer agreement, Mattapoisett, maximum achievable control technology, MCH, mechanosensitive ion channel, mechanotransduction, mediation, medical geography, medical research charities, Medicare, medication guide, medRxiv, Melanin concentrating hormone, melanopsin, melittin, membrane potential, membraneless organelle, mentorship, mercury, mercury chelation, Merrimack County, Meta analysis, metabolic cage studies, metabolic disease research, metabolic flux analysis, metabolic research peptides, metabolism, Metabolomics, metal toxicity, metal-binding protein, metallothionein, metaverse, methane, method validation, methylation, methylation domain, MFA, MHRA, MHRA registration, micro-perimeter, microbial limit, microbial opsins, microbiology, microcredit, microfinance, Microglia, microinsurance, microscale thermophoresis, microsegmentation, Microsoft Authenticator, Microsoft Cloud, Microsoft SEAL, Middleborough, Middlesex County, Middletown, MIE, migration, Milford, military end-use, minor source permit, misfolding, Mitophagy, mixed models, mixed reality, mobile authenticator, mobile phase preparation, mobile source, model organisms, modular enzyme, MOE, moist heat sterilization, molecular biology, molecular initiating event, monitoring, Monmouth County, monofill, Monomoy, Monroe, Monroe County, Montgomery County, Moran's I, morphine, Morris County, MOS, motilin, MOTION, motion tracking, Mount Kisco, Mount Pleasant, Mount Vernon, mouse, mouse dynamics, MP-SPDZ, MPC, MPG, MRC, mRNA, MSA, MSDS, MST, MTA, MTA negotiation, mTLS, mu receptor, mucolipin, multi-angle light scattering, multi-domain certificate, multi-factor authentication, multimerization, multimodal transport, multiparty computation, multiple regression, muscle wasting research, Muskeget, mutual TLS, N-linked glycosylation, NAAQS, nAChR, Nantucket, Nantucket Town, Narragansett, NASH research, national ambient air quality standards, national drug code, national emission standards for hazardous air pollutants, national priorities list, national security, natural product, Nav, NavIC, NCA, NCE, NDA, NDC, NEDD8, NEDDylation, neoendorphin, NES, NESHAP, net neutrality, net zero, net zero standard, network security, networking, networking event, neurodegeneration, Neuroinflammation, neurokinin, neuromedin, neuron, Neuropeptide, neuropeptide Y, neuroprotection, neuroscience, neurotensin, neurotransmitter, New Bedford, New Canaan, New Castle, New Castle County, new chemical entity, new drug application, New Haven County, New London, New London County, New product, New Rochelle, New Shoreham, new source performance standards, new source review, Newburgh, Newport, Newport County, next gen GLP-1, NFT, NGO, NHP, Niagara County, NICE, nickel, nicotinic acetylcholine receptor, NIH, NIH guidelines, NIST 800-171, NIST 800-53, NIST guidelines, nitric oxide, nitrogen dioxide, nitrous oxide, NLS, NMDA, NMR, NMR peptide analysis, no observed adverse effect level, NO2, NOAEL, nociceptin, nociception, Nomans Land, non-compartmental analysis, non-fungible token, non-GLP studies, non-human primate, non-point source, non-profit, non-qualified stock option, non-ribosomal peptide, non-viable monitoring, nona-arginine, nonattainment area, nonlinear regression, NOP, Norepinephrine, Norfolk County, North Castle, North Haven, North Kingstown, North Providence, North Salem, North Stonington, Northampton County, Northern Ireland protocol, Norwalk, Norwegian research chems, Not for human consumption, novel peptide drugs, Novi, NPL, NPY, NRPS, NSF, NSO, NSPS, NSR, nuclear export signal, nuclear localization signal, nuclear pore, nuclear receptor, nuclear transport, nucleic acid testing, nucleolus, nurse practitioner, nutraceuticals, nutrition science, O-GlcNAc, O3, Oak Bluffs, OAuth, obesity research peptide, obesity society, obesity week, oblivious RAM, oblivious transfer, occupational health, Ocean County, ocean freight, ODA, OFAC, OFCCP, official development assistance, OIDC, Okta, Old Lyme, Old Saybrook, oligoarginine, oligodendrocyte, oligomerization, one health, Oneida County, online course, Onondaga County, Ontario County, OOG, open access, OpenFHE, OpenID Connect, operating permit, opioid, opioid receptor, opsins, optimization, Optogenetics, Orai, oral presentation, ORAM, Orange, Orange County, Orangetown, Orexin, organic residue, organization validation certificate, organoid research, ORL1, Orleans, Orleans County, orphan designation, orphan drug, orphan exclusivity, orphanin FQ, OSHA, osmosensing, Ossining, Oswego County, OT, Otsego County, out-of-band authentication, out-of-gauge, outcomes research, outer packaging, outside-in tracking, OV certificate, overpack, Oxford County, oxidation domain, ozone, P-body, P2X, PA, PaaS, PACAP, pacemaker channel, package insert, packaging, packaging test, packing group, packing instruction, packing list, pain, pair feeding, pair feeding studies, PALISADE, PAM, pancreatic beta cell research, pancreatic polypeptide, paragraph IV certification, parametric monitoring, parametric release, paraspeckle, Paris Agreement, Parkinson disease, partially homomorphic encryption, particle count, particulate matter, pass-through, Passaic County, passive container, passkey, passwordless, PASylation, Patch clamp, patch management, patent challenge, patent search, pathology, patient counseling, patient information leaflet, patient registry, patient-oriented research, patient-reported outcome, Pawtucket, pay for success, payment diversion fraud, payment fraud, payment terms, payroll, Pb, PBAC, PBFT, PBPK modeling, PCI DSS, PCR, pediatric exclusivity, pediatric investigation plan, pediatric study plan, peer review, PEGylation, Pelham, Pelham Manor, pen test, penalty, penetratin, penetration testing, penicillamine, Penobscot County, pension, PEP, PEP-1, peptidases, peptide aliquot, peptide bioactivity, peptide content assay, peptide cyclization, peptide delivery, peptide drug, peptide drug development, peptide formulation, peptide handling protocol, peptide import, peptide kopen, peptide mapping, peptide net weight, Peptide purification, Peptide reconstitution, peptide reviews, peptide salt form, peptide sequence analysis, Peptide solubility, Peptide storage, peptide supplier Germany, peptide synthesis, peptide synthesis technology, peptide therapeutic, peptide therapeutics research, peptide vendor Europe, peptide vial, peptides for research France, peptidomimetic, peptoid, performance-oriented packaging, periodic monitoring, permeability, permeation, permit shield, personal data, personalized medicine, personnel monitoring, pexophagy, pH meter calibration, pH regulation, Ph. Eur., pharma R&D peptides, pharmacist, Pharmacodynamics, pharmacoeconomics, Pharmacogenomics, pharmacokinetics, pharmacology, pharmacopoeia, pharmacovigilance, phase 3 trial peptide, PHE, Philadelphia, philanthropy, Phishing, phone-as-a-token, phosphatase, phosphate homeostasis, phosphorylation, phototransduction, physician, physician assistant, physiologically based pharmacokinetics, physiology, PI, Piezo, pig, Pike County, PIM, Pima County, Ping Identity, PIP, pipette calibration, PIR, Piscataquis County, PK/PD modeling, PKI, planar lipid bilayer, planetary health, plasma arc, plasma collection, Plum Island, Plymouth, Plymouth County, PM10, PM2.5, PMDA, PML body, PoA, Pocomo, PoET, POI, point of interest, point source, policy-based access control, Polish lab supply, politically exposed person, pollutant, pollution prevention, Polpis, polyarginine, polycystin, polyglutamine disease, polyphemusin, polyproline helix, POMC, population health, Port Chester, Port Jervis, Portsmouth, Portuguese peptides, PoS, positional tracking, post-closure care, post-marketing surveillance, poster presentation, potassium channel, potency, potentiometry, Poughkeepsie, Pound Ridge, PoW, power analysis, PP, PPAR, PPE, PPII helix, practical byzantine fault tolerance, precautionary statements, precision, precision medicine, preclinical development, precursor chemicals, preferential origin, premium peptides, Preparative HPLC, preprint, prescribing information, prevention of significant deterioration, prime editing, Prince George's County, prion disease, PRISM, privacy, privacy impact assessment, Privacy policy, privacy rights, Privacy Shield, private information retrieval, privileged access management, privileged identity management, PRO, product liability, professional development, professional indemnity, proforma invoice, project cargo, proof of authority, proof of elapsed time, proof of stake, proof of work, proopiomelanocortin, proper shipping name, proprioception, proteases, proteasome, protegrin, protein folding, protein hydrolysates, proteoglycan, Proteomics, proteostasis, protocol review, Providence, Providence County, Provincetown, provisional tolerable monthly intake, provisional tolerable weekly intake, proxy detection, pruritus, PSD, Pseudonymization, PSP, PTMI, PTWI, Public health, public key infrastructure, publication rights, published data, PubMed, purinergic receptor, purple team, push notification, PXR, pyrogen free, pyrolysis, PYY, QALY, QCM, QCM-D, QOL, quality assurance, quality control, quality control peptides, quality management, quality of life, quality-adjusted life year, quartz crystal microbalance, quartz crystal microbalance with dissipation monitoring, Quidnet, Quorum, QZSS, race to zero, Ramapo, Ran, ranalexin, random coil, randomization, range, Ransomware, ransomware attack, rapid microbiology, rare disease, RASP, rat, raw material testing, RBAC, RCRA, rDNA, re-identification, real time stability, Real world data, real-world evidence, ReBAC, receptor binding assays, receptor tyrosine kinase, reclamation, recombinant DNA, recombinant factor C, record keeping, recordkeeping, recovery, recycling, red team, reduction domain, reefer container, reefer trailer, reefer truck, reefer vessel, reference dose, reference standard peptides, reformulation, refrigerated transport, refrigerated warehouse, refrigerator validation, Refund policy, regional greenhouse gas initiative, registry data, Regulatory affairs, regulatory compliance, relationship-based access control, release, relying party, remediation, REMS, renewal, Rensselaer County, repeatability, repeated measures, replicated secret sharing, reportable quantity, reporting, repositioning, reproducibility, repurposing, research articles, research chemicals EU, Research collaboration, research exemption, research peptides EU, research peptides for sale, research peptides Germany, research use only, residual risk, resource conservation and recovery act, respiratory protection, response surface methodology, resting potential, restricted parties list, restricted stock unit, retail pharmacy, retatrutide 40mg, retatrutide 50mg, retatrutide CAS 2381089-83-2, retatrutide clinical trial research, retatrutide COA, retatrutide endotoxin tested, retatrutide europe, retatrutide for sale, retatrutide France, retatrutide Germany, retatrutide HPLC, retatrutide molecular weight, retatrutide MS/MS, retatrutide Netherlands, retatrutide peptide, retatrutide purity 99, retatrutide research chemical, retatrutide sequence, retatrutide Spain, retatrutide vs semaglutide, retatrutide vs tirzepatide, retest date, retinoic acid receptor, retirement plan, retro-inverso peptide, retrocyclin, Return policy, reuse, review articles, review board, rFC, RfD, RGGI, rhodopsin, ribophagy, ribosomal peptide, RID, risk assessment, risk evaluation and mitigation strategy, risk management, risk management plan, risk review, risk-based authentication, RMP, RNA therapy, ro-ro, robustness, Rochester, Rockingham County, role-based access control, roll-on/roll-off, root store, rootkit, route optimization, RP, RQ, RSM, RSU, RTK, RUO peptides, Rutland County, RWD, RWE, RXR, ryanodine receptor, Rye, Rye Brook, RyR, S/MIME, SaaS, SAE, safety data sheet, safety factor, Sagadahoc County, SAL, Salem County, salvage packaging, salvage pathway, SAML, sample size calculation, SAN certificate, San Joaquin Valley APCD, sanctioned countries, sanctions screening, Sandwich, SAR, Saratoga County, SAST, satellite navigation, SaTScan, SAXS, SBMA, SBOM, SBTi, SCA, SCALE-MAMBA, Scarsdale, SCC, SCCs, Schenectady County, Schoharie County, Schrems II, Schuylkill County, science-based target, scientific computing, scientific meetings, Scopus, screening, SDP, SDS, sea freight, Seahorse assay, seal, SEC, secondary structure, secret sharing, section 14, Section 702, secure landfill, secure multiparty computation, secure socket layer, Security Assertion Markup Language, security assessment, security information and event management, security key, security operations center, security orchestration automation and response, selenium homeostasis, self-assembly, Seneca County, sensitive data, sensor fusion, serious adverse event, Serotonin, serum analysis, serverless security, service provider, settle plates, Shamir's secret sharing, shared responsibility model, shareholder primacy, Sharm el-Sheikh, sharps disposal, SHE, shelf life, Shelter Island, Shelton, shift left, Shimmo, shipping policy, sialylation, Siasconset, SIEM, sigmoidal curve, signal detection, signal word, signature dynamics, simultaneous localization and mapping, single packaging, single sign-on, SIP, siRNA, size exclusion chromatography, SLAM, slope factor, small claims court, small HSP, small-angle X-ray scattering, smart contract, SMC, smishing, Smithfield, SmPC, SMS-based authentication, SNP, SO2, SOAR, SOC, SOC 2, SOC 3, SOCE, social engineering, social engineering fraud, social enterprise, social finance, social impact bond, sodium channel, software bill of materials, software composition analysis, software-defined perimeter, solid-phase peptide synthesis, solution stability, somatostatin, Somers, Somerset, Somerset County, somewhat homomorphic encryption, source reduction, sourcing strategy, South Coast AQMD, South Kingstown, sovereign cloud, SP, Spanish peptide vendor, spatial analysis, spatial autocorrelation, spatial epidemiology, spatial interpolation, spatial scan statistic, SPDZ, specialty pharmacy, specialty recognition, specificity, speckle, spill, spill kit, spinocerebellar ataxia, split learning, SPPS, SPR, spyware, square wave voltammetry, SSL, SSL certificate, SSO, St. Lawrence County, stability data, stability study peptides, stablecoin, stack emission, stack test, stacking test, stakeholder capitalism, Stamford, standard contractual clauses, stapled peptide, state environmental agency, state implementation plan, StateRAMP, stationary source, statistical analysis, steatosis scoring, step-up authentication, Sterile filtration, sterile peptide, sterility assurance level, sterility testing, sterilization validation, steroid hormone receptor, Steuben County, STIM, stock options, Stonington, Stony Point, storage, store-operated calcium channel, STR, Strafford County, Stratford, stratification, Stratified medicine, stress granule, stretch sensing, subject alternative name, subsidiary risk, substance P, Suffolk County, sulfonamide, sulfonylurea receptor, sulfur dioxide, Sullivan County, summary of product characteristics, SUMO, SUMOylation, superfund, superfund site, supervisory authority, supplier audit, supply agreement, supply chain, SUR, surface plasmon resonance, Surfside, Surrogate endpoint, surveillance, survival analysis, SUSAR, suspected unexpected serious adverse reaction, suspicious activity report, suspicious transaction report, Susquehanna County, Sussex County, sustainability, SUTA, Swansea, swarm learning, Swedish research peptides, Swiss peptides, switchSENSE, SWV, synapse, Synaptic plasticity, synthetase, synthetic minor, synucleinopathy, system suitability, systems toxicology, t-closeness, t-test, tachyplesin, tactile feedback, tailoring enzyme, TALEN, Target validation, targeted therapy, TASTY, TAT, tauopathy, TCA, TDI, TDP-43 proteinopathy, technology review, technology transfer, telematics, temperature mapping, temperature monitoring, temperature monitoring system, temperature-controlled warehouse, temporin, terms and conditions, Terms of service, Terra, tetramerization, TFA salt, TFHE, TGA registration, The Obesity Society, theranostic, therapeutic peptide, thermal test, thermal treatment, thermosensing, theta-defensin, thioether, thiolation domain, thiotemplate mechanism, third party tested peptides, third-party audit, third-party logistics, threat hunting, threat intelligence, threshold, thyroid hormone receptor, tight junctions, Tioga County, tip, Tisbury, tissue collection, Titan key, Title V permit, Tiverton, TLS, TLS certificate, Tmax, tolerable daily intake, Tolland County, Tom Nevers, Tompkins County, Tor detection, TOTP, touch, Touch ID, toxic metals, toxicodynamics, toxicogenomics, Toxicokinetics, Toxicology, TRAAK, trace element homeostasis, trade agreement, trade and cooperation agreement, trade secret, training, trans-Atlantic data flow, transaction monitoring, Transcriptomics, transferrin, transferrin fusion, transient receptor potential, Translational research, transport information, transport layer security, transport regulations, transport studies, transportan, transportation management, transshipment, travel grant, treatment, TREK, tribal implementation plan, TRiC, trientine, triglyceride measurement, trimerization, triple agonist mechanism, triple agonist peptide, triple receptor agonist, trojan, TRP, TRP channel, TRPA1, TRPC, TRPM, TRPM8, TRPML, TRPP, TRPV, TRPV1, true minor, Trumbull, Truro, trust federation, trusted peptide vendor, TSDF, Tuckahoe, Tuckernuck, turbidimetric LAL, turn, two-pore domain potassium channel, ubiquitin, ubiquitin-proteasome system, ubiquitination, UF, UK Bribery Act, UK ETS, UK GDPR, UK regulation, UKCA marking, UKNI marking, UKRI, Ulster County, UN certified packaging, UN Global Compact, UN mark, UN number, UN recommendations, UN sanctions, UN specification packaging, uncertainty factor, unclassifiable area, unemployment tax, UNFCCC, uniform hazardous waste manifest, Union County, unit risk, UPS, UPSTREAM, uptake, urea peptidomimetic, US law, USDC, USDT, user directory, USP, Ussing chamber, validation, vector-borne disease, vehicle tracking, vendor qualification, venom peptide, verified peptides EU, veterinary medicine, viable monitoring, vibration test, VIP, virtual world, virus, visa status, visceroception, vishing, vision, vitamin D receptor, voice recognition, voice-based authentication, voltage clamp, voltage-gated ion channel, voltage-sensitive dye, volume of distribution, volume sensing, VPN, VPN detection, VR, VR controller, VSD, vulnerability management, vulnerability scanner, W-2, Waldo County, Wareham, warehouse management, warehousing, warranty disclaimer, Warren, Warren County, Warwick, Washington County, waste disposal, waste minimization, waste-to-energy, watch list screening, water soluble peptides, Waterford, Wauwinet, Wayne County, WCI, Web of Science, WebAuthn, webinar, WebRTC leak, website disclaimer, website security, Wellcome Trust, Wellfleet, West Greenwich, West Tisbury, Westbrook, Westerly, western climate initiative, Westport, White Plains, WHO ICTRP, wildcard certificate, Willingness to pay, Wilmington, Wilton, Windham County, Windows Hello, Windsor County, Windsor Framework, wireless sensors, withdrawal right, withholding tax, Woodbridge, Woodbury, Worcester County, work authorization, worker classification, workers compensation, workplace safety, workshop, worm, WTO, WTP, Wyoming County, X-ray crystallography, XR, XTEN, Yarmouth, Yates County, Yonkers, York County, Yorktown, young investigator award, YubiKey, ZDF rats, zebrafish, zero trust, zero trust architecture, zero trust network access, ZFN, zinc homeostasis, zoonosis, ZTA, ZTNA

Description
Product Tags

Premium Retatrutide (LY3437943) for Sale | 40mg per Vial | ≥98% Purity | 48-Hour Delivery Across EU & UK

Retatrutide (LY3437943): The Revolutionary Triple Agonist Redefining Metabolic Research

eupeptidelap.co.uk is proud to present Retatrutide 40mg (R&D Only) , a premium research-grade triple receptor agonist peptide manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with Retatrutide for sale that delivers exceptional purity, consistency, and documented quality .

Retatrutide (LY3437943) represents a groundbreaking advancement in metabolic research as the first-in-class triple agonist peptide targeting three key hormone receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon (GCG) receptor . This sophisticated 39-amino acid synthetic peptide is engineered to harness the complementary actions of all three incretin hormones, producing unprecedented metabolic effects that surpass even the most advanced dual agonists currently available .

The molecular formula of Retatrutide is C₂₂₁H₃₄₂N₄₆O₆₈, with a molecular weight of 4731.33 Da . Its unique structural design enables balanced activation of all three receptor types, creating a synergistic effect that addresses obesity and metabolic dysfunction from multiple angles. The triple agonism approach leverages:

GLP-1 Receptor Activation: Enhances insulin secretion in response to glucose, slows gastric emptying, and acts directly on brain appetite centers to suppress hunger
GIP Receptor Activation: Stimulates insulin release, influences fat metabolism and storage, and may affect brain reward pathways associated with food
Glucagon Receptor Activation: Increases energy expenditure, promotes lipolysis (fat breakdown), and reduces fat accumulation in the liver—while the potent glucose-lowering effects of GLP-1 and GIP offset glucagon’s potential blood sugar-raising effects

For researchers seeking to buy peptide online EU for investigations into obesity pharmacotherapy, type 2 diabetes, metabolic syndrome, or non-alcoholic fatty liver disease (NAFLD), eupeptidelap.co.uk offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data . Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of Retatrutide

Understanding the Triple Agonist Mechanism

To appreciate the innovation of Retatrutide, it’s essential to understand the hormones it mimics. The human body uses a complex network of signals to regulate appetite, blood sugar, and energy balance. Retatrutide simultaneously activates three key receptors in this network, creating a powerful, synergistic effect that addresses metabolic dysfunction from multiple angles .

Glucagon-Like Peptide-1 (GLP-1): Secreted by intestinal L-cells in response to meals, GLP-1 is a cornerstone of modern metabolic drugs. It enhances insulin secretion in a glucose-dependent manner (significantly reducing hypoglycemia risk), slows gastric emptying to increase feelings of fullness, and acts directly on the hypothalamus to suppress appetite. GLP-1 receptors are found in the pancreas, gastric mucosa, kidney, lung, heart, and brain regions including the hypothalamus, amygdala, and nucleus accumbens .

Glucose-Dependent Insulinotropic Polypeptide (GIP): Released from intestinal K cells postprandially, GIP was once thought less critical but has been re-evaluated following the success of dual agonists. GIP stimulates insulin secretion, reduces appetite by impacting gastric emptying, and influences adipose tissue by stimulating adipogenesis and inhibiting lipolysis. GIP receptors are expressed in pancreatic β-cells, adipose tissue, and the nervous system .

Glucagon: Produced in pancreatic α-cells, glucagon is traditionally known for raising blood sugar by stimulating hepatic glucose release. However, it also increases energy expenditure, promotes fat breakdown (lipolysis), and reduces hepatic fat accumulation. The challenge has always been harnessing these benefits without causing hyperglycemia—a challenge Retatrutide overcomes through balanced triple agonism .

Synergistic Effects on Appetite and Satiety

A primary driver of weight gain is an imbalance in hunger-regulating hormones. Retatrutide tackles this comprehensively :

GLP-1 Component: Acts on appetite centers in the hypothalamus, sending strong satiety signals and reducing desire to eat
GIP Component: May further enhance these effects by influencing the brain’s reward pathways associated with food
Combined Action: Along with slowed gastric emptying, this leads to a profound and sustained reduction in caloric intake that feels more manageable than willpower-based dieting alone

Enhancing Glycemic Control

For research into insulin resistance and prediabetes, Retatrutide offers robust support :

Incretin Effect: Both GLP-1 and GIP stimulate pancreatic insulin release only when blood glucose is elevated
Glucose-Dependent Mechanism: This significantly reduces the risk of hypoglycemia, a concern with older diabetes medications
Self-Regulating System: Glucagon receptor agonism is balanced by the potent insulin-stimulating effects of GLP-1 and GIP, enabling effective blood sugar management without dangerous peaks and troughs

Boosting Energy Expenditure and Fat Metabolism

This is where Retatrutide truly distinguishes itself from previous generations of metabolic peptides :

Increased Basal Metabolic Rate: Glucagon receptor agonism effectively “turns up the thermostat,” increasing overall energy expenditure
Hepatic Fat Reduction: Glucagon signaling helps reduce hepatic steatosis (fatty liver) by promoting the breakdown and export of stored fats
Lipolysis Stimulation: Releases stored fatty acids from adipose tissue to be used for energy
Targeted Fat Loss: This dual action specifically targets harmful visceral and ectopic fat deposits most strongly linked to metabolic disease and systemic inflammation

Key Research Applications

Obesity and Weight Loss Research

Retatrutide is extensively used in studies investigating body weight regulation, adipose tissue biology, and energy homeostasis. Clinical trials have demonstrated unprecedented weight loss results that set a new high bar for obesity pharmacotherapy research .

Phase 2 Clinical Trial Results: The landmark Phase 2 randomized, double-blind, placebo-controlled trial published in the New England Journal of Medicine (2023) enrolled 338 adults with BMI ≥30 (or ≥27 with a weight-related comorbidity) without type 2 diabetes. Results after 48 weeks showed :

Unprecedented Weight Loss: Participants receiving 12 mg weekly achieved a mean weight reduction of 24.2% of initial body weight—translating to approximately 26.4 kg (58 pounds)
Dose-Dependent Efficacy: Weight loss effects were clearly dose-dependent
Continued Loss Trajectory: Weight loss had not plateaued at 48 weeks, suggesting longer treatment could yield even greater results
Subgroup Analysis: Obese female subjects achieved up to 28.5% weight loss

Phase 3 TRIUMPH Program Results: Preliminary Phase 3 results reported in late 2025 demonstrated even more impressive outcomes :

28.7% Average Weight Loss: At 68 weeks, the 12 mg dose led to average weight loss of 28.7% (32.3 kg / 71.2 pounds)
Pain Reduction: In osteoarthritis patients, the study drug led to a 74.3% reduction in pain scores
Comparison: This exceeds the 22% weight loss achieved by Zepbound (tirzepatide) at 15 mg over 72 weeks

Type 2 Diabetes Research

Retatrutide has demonstrated exceptional efficacy in glycemic control research :

Phase 2 Diabetes Study: In 281 T2D subjects (± metformin) over 24 weeks, mean HbA1c reductions ranged from -0.43% (0.5 mg) to -2.02% (12 mg), compared to -1.41% for dulaglutide (1.5 mg)
Proof-of-Concept Study: After 12 weeks, retatrutide (0.5-12 mg) reduced placebo-adjusted HbA1c up to -1.60% at 3/6 mg doses, with weight loss of -8.96 kg at the highest dose

Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) Research

A particularly exciting finding from Phase 2 trials was Retatrutide’s powerful effect on liver fat :

Baseline Liver Fat: Participants had average liver fat content of approximately 20%
Post-Treatment Reduction: After 48 weeks on 12 mg dose, liver fat decreased by an average of over 86%
Complete Resolution: Nearly 86% of participants achieved complete resolution of excess liver fat (below 5%)

These findings strongly support the proposed mechanism of glucagon receptor agonism and position Retatrutide as a leading candidate for NAFLD/NASH research.

Cardiometabolic Research

Beyond weight loss, participants saw significant improvements in key health markers :

Blood Pressure Reduction: Dose-dependent decreases in both systolic and diastolic blood pressure
Lipid Profile Improvement: Reduced triglycerides, increased beneficial HDL cholesterol
Glycemic Normalization: Every participant with prediabetes at baseline in the 8 mg and 12 mg groups reverted to normal glycemic status by study end

Ongoing Phase 3 TRIUMPH Program Research

Based on highly successful Phase 2 results, Eli Lilly has launched an extensive Phase 3 clinical trial program (TRIUMPH) evaluating Retatrutide in diverse populations and for different indications :

Trial	Population	Duration	Primary Focus
TRIUMPH-1	Chronic weight management	Long-term	Obesity with/without T2D
TRIUMPH-2	Obstructive sleep apnea	Variable	OSA in obesity
TRIUMPH-3	1800 obese subjects with CVD	113 weeks	Cardiovascular outcomes
TRIUMPH-4	Knee osteoarthritis	Variable	Pain and function
TRIUMPH-5	Chronic low back pain	Variable	Pain management
TRIUMPH-CV	Cardiovascular/renal outcomes	Long-term	Major adverse cardiac events
TRIUMPH-MASH	Biopsy-confirmed NASH	12 months	Liver histology improvement

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources Retatrutide from certified GMP facilities with rigorous quality control protocols :

HPLC Purity Analysis: ≥98% purity verified by high-performance liquid chromatography
Mass Spectrometry Verification: Molecular weight confirmation via LC-HRMS
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Regulatory Compliance: Research Use Only (RUO) labeling with proper documentation
Safety Data Sheets (SDS): Provided with every order for safe handling

Chemical and Product Specifications

Specification	Detail
Product Name	Retatrutide (LY3437943) – R&D Only
CAS Number	2381089-83-2
Molecular Formula	C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight	4731.33 Da
Amino Acid Length	39 amino acids
Purity	≥98% (HPLC verified)
Appearance	White to off-white lyophilized solid
Solubility	H₂O: 20 mg/mL (ultrasonic; adjust pH to 9 with aqueous NH₃); DMSO: 50 mg/mL (ultrasonic)
Mechanism	Triple GLP-1/GIP/Glucagon receptor agonist
Storage (Powder)	-20°C to -80°C; stable up to 2 years at -80°C, 1 year at -20°C; protect from light and moisture
Storage (Reconstituted)	2-8°C for several weeks; aliquot to avoid freeze-thaw cycles
Shipping	Ambient temperature with protective packaging; cold chain available
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis, SDS provided

Stability and Handling Guidelines

Lyophilized Powder Storage: Retatrutide raw powder should be stored at -20°C to -80°C in a dry, dark environment, protected from light and moisture . In its lyophilized form, it can maintain potency for up to four years when properly handled. Use manual-defrost freezers or chest freezers rather than frost-free units to avoid temperature fluctuations. Store vials in the back of freezers (not door compartments) and maintain detailed temperature logs .

Reconstitution Protocol :

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using bacteriostatic water or sterile solvent according to research protocol
Inject solvent gently at a 45-degree angle, allowing it to run down the inside wall
Swirl gently—do not shake—to dissolve completely
Use fresh sterile needles for each vial access
Clean rubber stoppers with alcohol swabs before each puncture

Reconstituted Solution Storage: Once reconstituted, store at 2-8°C (refrigeration). Most formulations remain stable for several weeks to a few months. If freezing is necessary, aliquot into multiple smaller vials containing single-use amounts to minimize freeze-thaw cycles. Thaw completely in refrigerator over 24 hours—do not refreeze after use .

Protection from Light and Moisture :

Use amber or opaque vials to block UV light
Transfer to light-blocking containers if original packaging is transparent
Keep vials tightly sealed with desiccants when possible
Allow frozen vials to reach room temperature in a desiccator before opening

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥98% HPLC-verified purity
First-In-Class Triple Agonist: Simultaneous GLP-1, GIP, and glucagon receptor activation for synergistic research applications
High Concentration: 40mg per vial—substantial quantity for extended research studies
Unprecedented Weight Loss Research: Enables investigation of 24-28% body weight reduction in obesity models
Superior Efficacy: Phase 3 results demonstrate 28.7% average weight loss at 68 weeks
NAFLD/NASH Research: Reduces liver fat by >86% with nearly complete resolution in Phase 2
Glycemic Control Studies: HbA1c reductions up to -2.02% in T2D research models
Cardiometabolic Research: Improves blood pressure, lipid profiles, and insulin sensitivity
Appetite Regulation Studies: Triple mechanism targeting hypothalamic and reward pathways
Energy Expenditure Research: Glucagon agonism increases basal metabolic rate
Osteoarthritis Research: Reduces pain scores by 74.3% in obesity-related OA models
Sleep Apnea Research: Being studied in OSA populations (TRIUMPH-2)
Cardiovascular Outcomes Research: Phase 3 TRIUMPH-3 evaluating CVD endpoints
MASH/MAFLD Research: Dedicated Phase 2/3 trials in biopsy-confirmed NASH
Type 1 Diabetes Research: Potential applications in insulin reduction studies
Prediabetes Studies: 100% normalization of prediabetes at higher doses
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
Proper RUO Labeling: Full compliance with research-use-only regulations
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: Is Retatrutide 40mg (R&D Only) suitable for human consumption?

A: No. Retatrutide 40mg (R&D Only) from eupeptidelap.co.uk is strictly for research and laboratory use only . It is not for human or animal consumption, and must not be used for therapeutic, diagnostic, or clinical applications. While Retatrutide is being investigated in clinical trials by Eli Lilly, research-grade material is intended for investigational purposes only. Regulatory agencies have issued warnings against unapproved versions sold without proper RUO status . Researchers must handle this compound in accordance with institutional safety guidelines and local regulations.

Q: Is it legal to sell Retatrutide for research purposes in the UK?

A: The sale of unlicensed peptides like Retatrutide under “research use only” labeling occupies a legal grey area but is permissible under strict conditions . Legitimate buyers include academic labs, CROs, pharmaceutical R&D, and licensed clinics conducting non-human research . Proper documentation including Certificates of Analysis, Safety Data Sheets, and explicit RUO labeling is mandatory . The Medicines and Healthcare products Regulatory Agency (MHRA) may take enforcement action if marketing materials or user reviews indicate personal human use .

Q: What purity level can I expect when I buy Retatrutide from eupeptidelap.co.uk?

A: All Retatrutide from eupeptidelap.co.uk is tested to ≥98% purity by HPLC . Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.

Q: How effective is Retatrutide for weight loss in research models?

A: In clinical trials, Retatrutide has demonstrated unprecedented weight loss results. Phase 2 studies at 48 weeks showed 24.2% average weight loss at 12 mg dose . Phase 3 results at 68 weeks demonstrated 28.7% average weight loss (32.3 kg / 71.2 pounds) . This represents the highest weight loss recorded for any anti-obesity medication to date.

Q: How should I store Retatrutide for long-term stability?

A: Store lyophilized Retatrutide powder at -20°C to -80°C, protected from light and moisture . Powder is stable for up to 2 years at -80°C and 1 year at -20°C . Use manual-defrost freezers and store vials in the back (not doors). After reconstitution, store at 2-8°C for several weeks or aliquot into single-use portions and freeze at -80°C for up to 6 months. Avoid repeated freeze-thaw cycles .

Q: What is the molecular weight and formula of Retatrutide?

A: Retatrutide has the molecular formula C₂₂₁H₃₄₂N₄₆O₆₈ and a molecular weight of 4731.33 Da . It is a 39-amino acid peptide engineered for balanced activation of GLP-1, GIP, and glucagon receptors.

Q: What is the mechanism of action of Retatrutide?

A: Retatrutide is a first-in-class triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously . GLP-1 and GIP enhance insulin secretion, suppress appetite, and slow gastric emptying, while glucagon increases energy expenditure and promotes fat breakdown. The glucose-lowering effects of GLP-1 and GIP offset glucagon’s potential blood sugar-raising effects, creating a synergistic system .

Q: What research areas commonly use Retatrutide?

A: Retatrutide is widely used in obesity and weight loss research, type 2 diabetes research, NAFLD/NASH research, cardiometabolic studies, appetite regulation research, energy expenditure studies, osteoarthritis research, sleep apnea research, and cardiovascular outcomes research.

Q: Do you ship Retatrutide to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship Retatrutide to all European Union member states with our guaranteed 48 hour delivery peptide service. Shipments must comply with EU REACH and labeling standards for RUO compounds . Our EU fulfilment centre ensures rapid delivery without customs delays.

Q: What documentation do you provide with Retatrutide orders?

A: Every order includes a Certificate of Analysis with batch-specific purity data and a Safety Data Sheet (SDS) for safe handling . Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: How does Retatrutide compare to Tirzepatide?

A: Retatrutide (triple GLP-1/GIP/glucagon agonist) represents an advancement beyond Tirzepatide (dual GIP/GLP-1 agonist). Phase 2 trials showed 24.2% weight loss with Retatrutide at 48 weeks compared to approximately 21% with Tirzepatide at 72 weeks . Phase 3 Retatrutide results (28.7% at 68 weeks) exceed Tirzepatide’s 22% at 72 weeks . The addition of glucagon agonism likely drives enhanced effects on energy expenditure and liver fat reduction.

Q: What are the ongoing clinical trials for Retatrutide?

A: The Phase 3 TRIUMPH program includes multiple trials: TRIUMPH-1 (chronic weight management), TRIUMPH-2 (obstructive sleep apnea), TRIUMPH-3 (cardiovascular disease), TRIUMPH-4 (knee osteoarthritis), TRIUMPH-5 (chronic low back pain), TRIUMPH-CV (cardiovascular/renal outcomes), and TRIUMPH-MASH (NASH) . These studies have enrolled over 5,800 participants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Q: Does Retatrutide affect liver fat?

A: Yes, dramatically. In Phase 2 studies, participants on 12 mg dose saw liver fat decrease by over 86% from baseline (approximately 20% down to <5%). Nearly 86% achieved complete resolution of excess liver fat .

Q: What are the common adverse effects observed in Retatrutide trials?

A: The most common adverse events are gastrointestinal: nausea, diarrhea, constipation, and decreased appetite . These effects are consistent with the incretin mimetic drug class. The discontinuation rate for high dose was 18.2% versus 4% for placebo, with some discontinuations attributed to perceived excessive weight loss .

Q: Do you offer bulk quantities of Retatrutide for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs.

Advance Your Research with Retatrutide 40mg (R&D Only)

eupeptidelap.co.uk is your trusted source for Retatrutide 40mg (R&D Only) , the premium choice for researchers investigating metabolic disorders, obesity pharmacotherapy, diabetes, and NAFLD/NASH. As the first-in-class triple GLP-1/GIP/glucagon receptor agonist, Retatrutide represents a revolutionary tool for exploring the synergistic actions of all three incretin pathways and their unprecedented therapeutic potential. ...........................................

Whether you are exploring weight loss mechanisms, designing diabetes studies, investigating hepatic steatosis, or researching cardiometabolic outcomes, our rigorously tested compound provides the quality and consistency your work demands.

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.